Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

627
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
627
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

767
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
767
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.0K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

1.1K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.5K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.5K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
Same author

Prognostic Utility of the BCIS-CHIP Score in Imaging-Guided Percutaneous Coronary Intervention.

The American journal of cardiology·2026
Same author

Baseline Prolonged QRS Duration May Predict In-Hospital Outcomes of Patients With Acute Myocarditis: Multicenter Observational Study.

Circulation reports·2026
Same author

Minimizing command timing variability is a key factor in skilled actions.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Prognostic impact of pre-procedural blood pressure profiles on clinical outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Heart and vessels·2025
Same author

Variability of Circular Leg Movements Is Related to Footedness and Postural Stability.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2025

Related Experiment Video

Updated: Mar 25, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K

Evidence-based clinical practice guidelines for peptic ulcer disease 2015.

Kiichi Satoh1,2, Junji Yoshino3, Taiji Akamatsu3

  • 1Department of Gastroenterology, International University of Health and Welfare Hospital, 537-3 Iguchi, Nasushiobara-shi, Tochigi, 329-2763, Japan. kiichi@iuhw.ac.jp.

Journal of Gastroenterology
|February 17, 2016
PubMed
Summary

The Japanese Society of Gastroenterology updated peptic ulcer disease guidelines, covering H. pylori, NSAID ulcers, and surgical/conservative treatments. These evidence-based recommendations utilize the GRADE system for clinical questions.

Keywords:
Cyclooxygenase-2Duodenal ulcerGastric ulcerHelicobacter pylori eradicationLow-dose aspirinNonsteroidal anti-inflammatory drugPeptic ulcerStomach ulcer

More Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

2.1K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.7K

Related Experiment Videos

Last Updated: Mar 25, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

2.1K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.7K

Area of Science:

  • Gastroenterology
  • Clinical Practice Guidelines

Background:

  • Peptic ulcer disease management requires updated clinical practice guidelines.
  • The Japanese Society of Gastroenterology (JSGE) previously issued guidelines in 2014.

Purpose of the Study:

  • To provide an English version of the revised evidence-based clinical practice guidelines for peptic ulcer disease.
  • To address key aspects of peptic ulcer disease including bleeding, H. pylori eradication, NSAID-induced ulcers, and complications like perforation and stenosis.

Main Methods:

  • Development of 90 clinical questions (CQs) based on the JSGE 2014 guidelines.
  • Comprehensive literature search from 1983 to June 2012 across Medline, Cochrane, and Igaku Chuo Zasshi databases.
  • Application of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system for guideline development.

Main Results:

  • Guidelines cover seven key areas: bleeding ulcers, H. pylori eradication, non-eradication therapy, drug-induced ulcers, non-H. pylori/non-NSAID ulcers, surgical treatment, and conservative management for perforation/stenosis.
  • Therapeutic strategies prioritize ulcer complications, followed by medical interventions.
  • Treatment algorithms differentiate based on etiology (NSAID-related, H. pylori-positive, or other) and patient factors.

Conclusions:

  • The guidelines offer a structured approach to peptic ulcer disease management, integrating evidence-based recommendations.
  • Treatment pathways emphasize initial management of complications, followed by etiological treatment and maintenance therapy to prevent relapse.
  • The English version facilitates broader access to JSGE's updated recommendations for clinicians worldwide.